The incidence of oxyphenisatin-induced liver damage in chronic non-alcoholic liver disease. A controlled investigation.
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001706:Biopsy; D002400:Cathartics / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007659:Ketones / Q000009:adverse effects / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy*; D008107:Liver Diseases / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D013997:Time Factors
D000085:Acetates; D002400:Cathartics; D007211:Indoles; D007659:Ketones; D010636:Phenols; D010919:Placebos